Citations (74)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Erin Cummins & Francesco Leri. (2009) Animal studies trigger new insights on the use of methadone maintenance. Expert Opinion on Drug Discovery 4:5, pages 577-586.
Read now
Read now
Benjamin Maas, Thomas Kerr, Nadia Fairbairn, Julio Montaner & Evan Wood. (2006) Pharmacokinetic interactions between HIV antiretroviral therapy and drugs used to treat opioid dependence. Expert Opinion on Drug Metabolism & Toxicology 2:4, pages 533-543.
Read now
Read now
S. Giacomuzzi, G. Kemmler, M. Ertl & Y. Riemer. (2006) Opioid Addicts at Admission vs. Slow-Release Oral Morphine, Methadone, and Sublingual Buprenorphine Maintenance Treatment Participants. Substance Use & Misuse 41:2, pages 223-244.
Read now
Read now
Giedrius Vanagas, Zilvinas Padaiga & Eugenijus Bagdonas. (2006) Cost-Utility Analysis of Methadone Maintenance Treatment: A Methodological Approach. Substance Use & Misuse 41:1, pages 87-101.
Read now
Read now
DavidP. Desmond & JamesF. Maddux. (2000) Deaths Among Heroin Users in and out of Methadone Treatment. Journal of Maintenance in the Addictions 1:4, pages 45-61.
Read now
Read now
Angela D. Bryan, Jeffrey D. Fisher, William A. Fisher & Danielle M. Murray. (2000) Understanding Condom Use among Heroin Addicts in Methadone Maintenance Using the Information-Motivation-Behavioral Skills Model. Substance Use & Misuse 35:4, pages 451-471.
Read now
Read now
Stephen Magura, Andrew Rosenblum & EricM. Rodriguez. (1998) Changes in HIV Risk Behaviors Among Cocaine-Using Methadone Patients. Journal of Addictive Diseases 17:4, pages 71-90.
Read now
Read now
Joanne Neale. (1998) Reducing Risks: Drug Users' views of Accessing and Disposing of Injecting Equipment. Addiction Research 6:2, pages 147-163.
Read now
Read now
J. Strang & J. Sheridan. (1998) National and regional characteristics of methadone prescribing in England and Wales: local analyses of data from the 1995 national survey of community pharmacies. Journal of Substance Misuse 3:4, pages 240-246.
Read now
Read now
Joanne Neale. (1998) Drug Users' Views of Prescribed Methadone. Drugs: Education, Prevention and Policy 5:1, pages 33-45.
Read now
Read now
Kate Dolan, Alex D. Wodak & Wayne D. Hall. (1998) Methadone maintenance treatment reduces heroin injection in New South Wales prisons. Drug and Alcohol Review 17:2, pages 153-158.
Read now
Read now
John R. M. Caplehorn, Diana M. Hartel & Les Irwig. (1997) Measuring and Comparing the Attitudes and Beliefs of Staff Working in New York Methadone Maintenance Clinics. Substance Use & Misuse 32:4, pages 399-413.
Read now
Read now
John R. M. Caplehorn, Les Irwig & John B. Saunders. (1996) Physicians' Attitudes and Retention of Patients in Their Methadone Maintenance Programs. Substance Use & Misuse 31:6, pages 663-677.
Read now
Read now
John R. M. Caplehorn, Les Irwig, John B. Saunders & B. Chir. (1996) Attitudes and Beliefs of Staff Working in Methadone Maintenance Clinics. Substance Use & Misuse 31:4, pages 437-452.
Read now
Read now
John R. M. Caplehorn, M. Y. N. Stella Dalton, Francis Haldar, Ann-Marie Petrenas & James G. Nisbet. (1996) Methadone Maintenance and Addicts' Risk of Fatal Heroin Overdose. Substance Use & Misuse 31:2, pages 177-196.
Read now
Read now
Articles from other publishers (59)
Nadine Mahboub, Rana Rizk, Mirey Karavetian & Nanne de Vries. (2021) Nutritional status and eating habits of people who use drugs and/or are undergoing treatment for recovery: a narrative review. Nutrition Reviews 79:6, pages 627-635.
Crossref
Crossref
Thomas GeschwindeThomas Geschwinde. 2018. Rauschdrogen. Rauschdrogen
393
553
.
Yun-Hsiang Chen, Kuang-Lun Wu, Ming-Ta Tsai, Wei-Hsien Chien, Mao-Liang Chen & Yun Wang. (2017) Methadone enhances human influenza A virus replication. Addiction Biology 22:1, pages 257-271.
Crossref
Crossref
George E. Woody, Douglas Bruce, P. Todd Korthuis, Sumedha Chhatre, Sabrina Poole, Maureen Hillhouse, Petra Jacobs, James Sorensen, Andrew J. Saxon, David Metzger & Walter Ling. (2014) HIV Risk Reduction With Buprenorphine–Naloxone or Methadone. JAIDS Journal of Acquired Immune Deficiency Syndromes 66:3, pages 288-293.
Crossref
Crossref
August F. Holtyn, Mikhail N. Koffarnus, Anthony DeFulio, Sigurdur O. Sigurdsson, Eric C. Strain, Robert P. Schwartz, Jeannie-Marie S. Leoutsakos & Kenneth Silverman. (2014) The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: A randomized controlled trial. Preventive Medicine.
Crossref
Crossref
Georgina J. MacArthur, Eva van Velzen, Norah Palmateer, Jo Kimber, Anastasia Pharris, Vivian Hope, Avril Taylor, Kirsty Roy, Esther Aspinall, David Goldberg, Tim Rhodes, Dagmar Hedrich, Mika Salminen, Matthew Hickman & Sharon J. Hutchinson. (2014) Interventions to prevent HIV and Hepatitis C in people who inject drugs: A review of reviews to assess evidence of effectiveness. International Journal of Drug Policy 25:1, pages 34-52.
Crossref
Crossref
Thomas GeschwindeThomas Geschwinde. 2013. Rauschdrogen. Rauschdrogen
321
467
.
Linda Gowing, Michael F Farrell, Reinhard Bornemann, Lynn E Sullivan & Robert Ali. (2011) Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database of Systematic Reviews.
Crossref
Crossref
David S Metzger, George E Woody & Charles P O'Brien. (2010) Drug Treatment as HIV Prevention: A Research Update. JAIDS Journal of Acquired Immune Deficiency Syndromes 55:Supplement 1, pages S32-S36.
Crossref
Crossref
David S. Metzger & Yan Zhang. (2010) Drug Treatment as HIV Prevention: Expanding Treatment Options. Current HIV/AIDS Reports 7:4, pages 220-225.
Crossref
Crossref
Modi Jiao, Erica Greanya, Mazhar Haque, Eric Yoshida & John Soos. (2010) Methadone maintenance therapy in liver transplantation. Progress in Transplantation 20:3, pages 209-214.
Crossref
Crossref
Modi Jiao, Erica D. Greanya, Mazhar Haque, Eric M. Yoshida & John G. Soos. (2010) Methadone Maintenance Therapy in Liver Transplantation. Progress in Transplantation 20:3, pages 209-214.
Crossref
Crossref
Tressa Hanson, Sheila M. Alessi & Nancy M. Petry. (2008) Contingency management reduces drug‐related human immunodeficiency virus risk behaviors in cocaine‐abusing methadone patients. Addiction 103:7, pages 1187-1197.
Crossref
Crossref
Linda Gowing, Michael Farrell, Reinhard Bornemann, Lynn E Sullivan & Robert Ali. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
. 2007. Rauschdrogen. Rauschdrogen
295
438
.
Gary P. Jeffrey, Gerry MacQuillan, Fern Chua, Sam Galhenage, Judith Bull, Emma Young, Gary Hulse & George O'Neil. (2007) Hepatitis C virus eradication in intravenous drug users maintained with subcutaneous naltrexone implants. Hepatology 45:1, pages 111-117.
Crossref
Crossref
Paula J. Lum & Jacqueline Peterson Tulsky. (2006) The medical management of opioid dependence in HIV primary care settings. Current HIV/AIDS Reports 3:4, pages 195-204.
Crossref
Crossref
Hayley Diana Mark, Joy Nanda, Annet Davis-Vogel, Helen Navaline, Roseanne Scotti, Rasanjali Wickrema, David Metzger & Julie Sochalski. (2006) Profiles of Self-Reported HIV-Risk Behaviors Among Injection Drug Users in Methadone Maintenance Treatment, Detoxification, and Needle Exchange Programs. Public Health Nursing 23:1, pages 11-19.
Crossref
Crossref
Clyde B. McCoy, Lisa R. Metsch, Mary Comerford, Wei Zhao, Amanda J. Coltes & Sarah E. Messiah. (2005) Trends of HIV Risk Behaviors in a Cohort of Injecting Drug Users and Their Sex Partners in Miami, Florida, 1988–1998. AIDS and Behavior 9:2, pages 187-199.
Crossref
Crossref
Saman Zamani, Masahiro Kihara, Mohammad Mehdi Gouya, Mohsen Vazirian, Masako Ono-Kihara, Emran Mohammad Razzaghi & Seiichi Ichikawa. (2005) Prevalence of and factors associated with HIV-1 infection among drug users visiting treatment centers in Tehran, Iran. AIDS 19:7, pages 709-716.
Crossref
Crossref
Lynn E. Sullivan, David S. Metzger, Paul J. Fudala & David A. Fiellin. (2005) Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users. Addiction 100:2, pages 150-158.
Crossref
Crossref
L Gowing, M Farrell, R Bornemann & R Ali. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
S.Kelly Avants, Arthur Margolin, Mary Helen Usubiaga & Cheryl Doebrick. (2004) Targeting HIV-related outcomes with intravenous drug users maintained on methadone: A randomized clinical trial of a harm reduction group therapy. Journal of Substance Abuse Treatment 26:2, pages 67-78.
Crossref
Crossref
. (2004) Recommendations for Incorporating Human Immunodeficiency Virus (HIV) Prevention into the Medical Care of Persons Living with HIV. Clinical Infectious Diseases 38:1, pages 104-121.
Crossref
Crossref
David S. Metzger & Helen Navaline. (2003) Human Immunodeficiency Virus Prevention and the Potential of Drug Abuse Treatment. Clinical Infectious Diseases 37:s5, pages S451-S456.
Crossref
Crossref
S. M. Giacomuzzi, Y. Riemer, M. Ertl, G. Kemmler, H. Rössler, H. Hinterhuber & M. Kurz. (2003) Buprenorphine versus methadone maintenance treatment in an ambulant setting: a health‐related quality of life assessment. Addiction 98:5, pages 693-702.
Crossref
Crossref
Ka-hing Wong, Shui-shan Lee, Wei-ling Lim & Hon-kei Low. (2003) Adherence to methadone is associated with a lower level of HIV-related risk behaviors in drug users. Journal of Substance Abuse Treatment 24:3, pages 233-239.
Crossref
Crossref
Leigh A. Henderson, David Vlahov, David D. Celentano & Steffanie A. Strathdee. (2003) Readiness for Cessation of Drug Use Among Recent Attenders and Nonattenders of a Needle Exchange Program. JAIDS Journal of Acquired Immune Deficiency Syndromes 32:2, pages 229-237.
Crossref
Crossref
Thomas GeschwindeThomas Geschwinde. 2003. Rauschdrogen. Rauschdrogen
243
371
.
Robert Heimer, Sarah Bray, Scott Burris, Kaveh Khoshnood & Kim M. Blankenship. (2002) Structural interventions to improve opiate maintenance. International Journal of Drug Policy 13:2, pages 103-111.
Crossref
Crossref
Arthur I. Alterman, Charles P. O’Brien, A. Thomas McLellan & James R. McKay. 2001. Comprehensive Handbook of Psychopathology. Comprehensive Handbook of Psychopathology
623
640
.
Abu S. Abdul-Quader, Don C. Des Jarlais, Anindya Chatterjee, A. Elizabeth Hirky & Samuel R. Friedman. 2002. Preventing HIV in Developing Countries. Preventing HIV in Developing Countries
283
312
.
Alan Shiell & Matthew G Law. (2001) The cost of hepatitis C and the cost–effectiveness of its prevention. Health Policy 58:2, pages 121-131.
Crossref
Crossref
Gregory S. Zaric & Margaret L. Brandeau. (2016) Optimal Investment in a Portfolio of HIV Prevention Programs. Medical Decision Making 21:5, pages 391-408.
Crossref
Crossref
Katherine Pérez, Anna Rodés, Mercé Meroño & Jordi Casabona. (2001) Comportamientos de riesgo en usuarios de drogas por vía parenteral en tratamiento con metadona. Medicina Clínica 116:8, pages 315-316.
Crossref
Crossref
Hanne Thiede, Holly Hagan & Christopher S. Murrill. (2000) Methadone treatment and hiv and hepatitis band C risk reduction among injectiors in the seattle area. Journal of Urban Health 77:3, pages 331-345.
Crossref
Crossref
Gregory S. Zaric, Margaret L. Brandeau & Paul G. Barnett. (2000) Methadone Maintenance and HIV Prevention: A Cost-Effectiveness Analysis. Management Science 46:8, pages 1013-1031.
Crossref
Crossref
. (2000) HIV transmission and the cost-effectiveness of methadone maintenance. American Journal of Public Health 90:7, pages 1100-1111.
Crossref
Crossref
James L. Sorensen & Amy L. Copeland. (2000) Drug abuse treatment as an HIV prevention strategy: a review. Drug and Alcohol Dependence 59:1, pages 17-31.
Crossref
Crossref
Joanne Neale. (2000) Methadone, methadone treatment and non-fatal overdose. Drug and Alcohol Dependence 58:1-2, pages 117-124.
Crossref
Crossref
David S. Metzger, Helen Navaline & George E. Woody. 2000. Handbook of HIV Prevention. Handbook of HIV Prevention
147
157
.
David R. Gibson, Neil M. Flynn & John J. McCarthy. (1999) Effectiveness of methadone treatment in reducing HIV risk behavior and HIV seroconversion among injecting drug users. AIDS 13:14, pages 1807-1818.
Crossref
Crossref
RALF GERLACH & JOHN R.M. CAPLEHORN. (2009) Attitudes and beliefs of doctors prescribing methadone to addicts in the Westfalen‐Lippe region of Germany. Drug and Alcohol Review 18:2, pages 163-170.
Crossref
Crossref
Jeff Ward, Wayne Hall & Richard P Mattick. (1999) Role of maintenance treatment in opioid dependence. The Lancet 353:9148, pages 221-226.
Crossref
Crossref
John R.M Caplehorn, Thomas S Lumley & Les Irwig. (1998) Staff attitudes and retention of patients in methadone maintenance programs. Drug and Alcohol Dependence 52:1, pages 57-61.
Crossref
Crossref
Maureen Miller & Denise Paone. (1998) Social network characteristics as mediators in the relationship between sexual abuse and HIV risk. Social Science & Medicine 47:6, pages 765-777.
Crossref
Crossref
John R.M. Caplehorn, Thomas S. Lumley, Les Irwig & John B. Saunders. (1998) Changing attitudes and beliefs of staff working in methadone maintenance programs. Australian and New Zealand Journal of Public Health 22:4, pages 505-508.
Crossref
Crossref
Robert Heimer. (1998) Can Syringe Exchange Serve as a Conduit to Substance Abuse Treatment?. Journal of Substance Abuse Treatment 15:3, pages 183-191.
Crossref
Crossref
Andy D Peters & Margaret M Reid. (1998) Methadone treatment in the Scottish context: outcomes of a community-based service for drug users in Lothian. Drug and Alcohol Dependence 50:1, pages 47-55.
Crossref
Crossref
Robert Power. (1998) Contemporary Issues concerning Illicit Drug Use in the British Isles. Journal of Drug Issues 28:1, pages 1-8.
Crossref
Crossref
Thomas GeschwindeThomas Geschwinde. 1998. Rauschdrogen. Rauschdrogen
205
314
.
STEFFANIE A. STRATHDEE, DAVID M. PATRICK, CHRISTOPHER P. ARCHIBALD, MARIANNA OFNER, PETER G. A. CORNELISSE, MICHAEL REKART, MARTIN T. SCHECHTER & MICHAEL V. O'SHAUGHNESSY. (2006) Social determinants predict needle‐sharing behaviour among injection drug users in Vancouver, Canada. Addiction 92:10, pages 1339-1347.
Crossref
Crossref
NICK CROFTS, LUCIANO NIGRO, KIMBERLEY OMAN, ELAINE STEVENSON & JOHN SHERMAN. (2006) Methadone maintenance and hepatitis C virus infection among injecting drug users. Addiction 92:8, pages 999-1005.
Crossref
Crossref
L.M Camacho, N.G Bartholomew, G.W Joe & D.D Simpson. (1997) Maintenance of HIV risk reduction among injection opioid users: a 12 month posttreatment follow-up. Drug and Alcohol Dependence 47:1, pages 11-18.
Crossref
Crossref
Alex Wodak & Peter Lurie. (1997) A Tale of Two Countries: Attempts to Control HIV among Injecting Drug Users in Australia and the United States. Journal of Drug Issues 27:1, pages 117-134.
Crossref
Crossref
Shane Darke, Joanne Ross & Wayne Hall. (1996) Prevalence and correlates of the injection of methadone syrup in Sydney, Australia. Drug and Alcohol Dependence 43:3, pages 191-198.
Crossref
Crossref
Alex Wodak & Kate Dolan. (1996) 8.5 HIV prevention in the community: injecting drug users. Medical Journal of Australia 165:5, pages 266-267.
Crossref
Crossref
L.Mabel Camacho, Norma G. Bartholomew, George W. Joe, Melynda A. Cloud & D.Dwayne Simpson. (1996) Gender, cocaine and during-treatment HIV risk reduction among injection opioid users in methadone maintenance. Drug and Alcohol Dependence 41:1, pages 1-7.
Crossref
Crossref
AMANDA BAKER, NICKY KOCHAN, JULIE DIXON, ALEX WODAK & NICK HEATHER. (1995) HIV risk-taking behaviour among injecting drug users currently, previously and never enrolled in methadone treatment. Addiction 90:4, pages 545-554.
Crossref
Crossref